SandboxAQ Head of Product for AI Simulation Platforms, Arman Zaribafiyan, is an IQT Vancouver/Pacific Rim 2024 Speaker – Inside Quantum Technology Source Cluster: Inside Quantum Technology Source Node: 1968474Time Stamp: Apr 26, 2024
Eisai Completes Submission of LEQEMBI (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease to the U.S. FDA Source Cluster: JCN Newswire Source Node: 1961159Time Stamp: Mar 31, 2024
“LEQEMBI Intravenous Infusion”Lecanemab) for the Treatment of Alzheimer’s Disease to be Launched in Japan on December 20 Source Cluster: JCN Newswire Source Node: 1925109Time Stamp: Dec 14, 2023
Scientists Unearth Brand New Links Between Genes and Disease in Our Blood Source Cluster: Singularity Hub Source Node: 1898789Time Stamp: Oct 6, 2023
“LEQEMBI Intravenous Infusion” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Japan Source Cluster: JCN Newswire Source Node: 1893980Time Stamp: Sep 25, 2023
Week Ahead – Bracing for next week’s earnings, rate decisions, and major economic data – MarketPulse Source Cluster: MarketPulse Source Node: 1863657Time Stamp: Jul 21, 2023
Week Ahead – A valentine’s day treat Source Cluster: MarketPulse Source Node: 1801219Time Stamp: Feb 10, 2023
Stocks rally as BOE intervenes, promising news from Biogen, bitcoin Source Cluster: MarketPulse Source Node: 1701615Time Stamp: Sep 28, 2022